Her-2/ neu and Topoisomerase iiα in Breast Cancer

By Järvinen T.A.H.  

Breast Cancer Research and Treatment, Vol. 78, Iss. 3, 2003-04 ,pp. : 299-311

Springer Publishing Company

Access to resources Recommend Favorite

Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial

By O’Malley F.   Chia S.   Tu D.   Shepherd L.   Levine M.   Huntsman D.   Bramwell V.   Andrulis I.   Pritchard K.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 401-409

Springer Publishing Company

Access to resources Recommend Favorite

Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes

By Varga Zsuzsanna  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 929-935

Springer Publishing Company

Access to resources Recommend Favorite

Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk

By Langsenlehner Uwe   Renner Wilfried   Yazdani-Biuki Babak   Eder Tanja   Wascher Thomas   Paulweber Bernhard   Clar Heimo   Hofmann Günter   Samonigg Hellmut   Krippl Peter  

Breast Cancer Research and Treatment, Vol. 97, Iss. 1, 2006-05 ,pp. : 67-72

Springer Publishing Company

Access to resources Recommend Favorite

Male accessory breast cancer successfully treated with endocrine therapy: A case report

By Bi Lintao   Li Jun   Shi Zhangzhen   Zhu Zhenxing   Lu Zhenxia  

Oncology Letters, Vol. 10, Iss. 4, 2015-10 ,pp. : 2495-2498

Spandidos Publications

Access to resources Recommend Favorite